<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T09:13:52Z</responseDate>
  <request identifier="oai:figshare.com:article/34015603" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34015603</identifier>
        <datestamp>2026-09-28T17:23:52Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Summary translation rates by multiple definitions.&lt;/p&gt;</dc:title>
          <dc:creator>Timothy R. Entwistle (25132513)</dc:creator>
          <dc:creator>William R. Cowey (25132516)</dc:creator>
          <dc:creator>Eliza Stokoe (25132519)</dc:creator>
          <dc:creator>John P. Stone (9176108)</dc:creator>
          <dc:creator>James E. Fildes (9176126)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>two reviewers blinded</dc:subject>
          <dc:subject>physical interventions ).</dc:subject>
          <dc:subject>open science framework</dc:subject>
          <dc:subject>may substantially overestimate</dc:subject>
          <dc:subject>9 &amp;# 8211</dc:subject>
          <dc:subject>847 records identified</dc:subject>
          <dc:subject>6 %, likely</dc:subject>
          <dc:subject>2 &amp;# 8211</dc:subject>
          <dc:subject>small rodent models</dc:subject>
          <dc:subject>routine clinical use</dc:subject>
          <dc:subject>specified regulatory categories</dc:subject>
          <dc:subject>small animal models</dc:subject>
          <dc:subject>market safety concerns</dc:subject>
          <dc:subject>conflates trial entry</dc:subject>
          <dc:subject>22 march 2022</dc:subject>
          <dc:subject>human clinical trials</dc:subject>
          <dc:subject>6 %; 95</dc:subject>
          <dc:subject>market safety outcomes</dc:subject>
          <dc:subject>human therapeutic outcomes</dc:subject>
          <dc:subject>novel preclinical therapies</dc:subject>
          <dc:subject>class regulatory approval</dc:subject>
          <dc:subject>animal models</dc:subject>
          <dc:subject>clinical trials</dc:subject>
          <dc:subject>safety outcomes</dc:subject>
          <dc:subject>market safety</dc:subject>
          <dc:subject>human approval</dc:subject>
          <dc:subject>regulatory approval</dc:subject>
          <dc:subject>regulatory reality</dc:subject>
          <dc:subject>preclinical promise</dc:subject>
          <dc:subject>novel first</dc:subject>
          <dc:subject>therapeutic intervention</dc:subject>
          <dc:subject>therapeutic development</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>via pubmed</dc:subject>
          <dc:subject>third adjudicating</dc:subject>
          <dc:subject>syrcle tool</dc:subject>
          <dc:subject>syrcle guidance</dc:subject>
          <dc:subject>synthesised descriptively</dc:subject>
          <dc:subject>section s3</dc:subject>
          <dc:subject>s1 file</dc:subject>
          <dc:subject>proportion progressing</dc:subject>
          <dc:subject>predictive validity</dc:subject>
          <dc:subject>osf (&lt;</dc:subject>
          <dc:subject>market analysis</dc:subject>
          <dc:subject>guinea pigs</dc:subject>
          <dc:subject>full strategy</dc:subject>
          <dc:subject>effect approvals</dc:subject>
          <dc:description>&lt;p&gt;Summary translation rates by multiple definitions.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T17:23:42Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358773.t005</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Summary_translation_rates_by_multiple_definitions_p_/34015603</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
